We may earn an affiliate commission when you visit our partners.

Cancer Immunotherapy

Jeffrey Schlom, James W. Hodge, Claudia Palena, John W. Greiner, Kwong-Yok Tsang, Benedetto Farsaci, Ravi A. Madan, and James L. Gulley

This article reviews progress made in the design and development of recombinant poxviral-based vaccines that express transgenes for tumor-associated antigens (TAAs) and human T-cell co-stimulatory molecules (designated TRICOM).

Read this on Amazon

Or Download the Kindle Edition

Read this for free with Kindle Unlimited

Available editions

Cancer Immunotherapy: Chapter 20. Recombinant TRICOM-based Therapeutic Cancer Vaccines: Lessons Learned

Kindle Edition

Save this book

Save Cancer Immunotherapy to your list so you can find it easily later:

Save

Help others find this book page by sharing it with your friends and followers:

Facebook

Copy Link

Length: 684 pages

Share and help others discover this book.

Facebook

Link

Our mission

OpenCourser helps millions of learners each year. People visit us to learn workspace skills, ace their exams, and nurture their curiosity.

Our extensive catalog contains over 50,000 courses and twice as many books. Browse by search, by topic, or even by career interests. We'll match you to the right resources quickly.

Find this site helpful? Tell a friend about us.

Affiliate disclosure

We're supported by our community of learners. When you purchase or subscribe to courses and programs or purchase books, we may earn a commission from our partners.

Your purchases help us maintain our catalog and keep our servers humming without ads.

Thank you for supporting OpenCourser.